What is Benlysta?

Category: Prescription Drugs

true

Generic name: Belimumab

Benlysta®, a brand name for belimumab, is a medication used to treat systemic lupus erythematosus. It works by decreasing the activity of a certain type of cell in the immune system so the body’s overall autoimmune response is lowered.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Systemic lupus erythematosus 58 39
Autoimmune hemolytic anemia 1 0
Mixed connective tissue disease 1 1
Psoriasis 1 0
Psoriatic arthritis 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
7
Moderate
10
Mild
13
None
9

Commonly reported side effects and conditions associated with Benlysta

Side effect Patients
Nausea 5
Fatigue 3
Headaches 3
Insomnia 3
Diarrhea 2
Fever/chills 2

Show all 46 reported side effects

Dosages

Based on patients currently taking Benlysta

Dosage Patients
200 mg weekly 4
400 mg every 4 weeks 3
1 other monthly 1
1 hr every 4 weeks 1
1 mg every 4 weeks 1
1 other every 4 weeks 1
10 mg monthly 1
120 mg every 4 weeks 1
200 mg monthly 1
200 mg every 4 weeks 1

See all 18 dosages

Why patients stopped taking Benlysta

Multiple reasons could be selected

Reason Patients
Side effects too severe 6
Did not seem to work 5
Doctor's advice 5
Other 5
Course of treatment ended 2
Expense 2
Personal research 1
See all 18 patients who've stopped taking Benlysta

Duration

Currently taking Benlysta

Duration Patients
1 - 6 months 6
6 months - 1 year 3
1 - 2 years 4
2 - 5 years 8
5 - 10 years 1
10 years or more 1

Stopped taking Benlysta

Duration Patients
Less than 1 month 6
1 - 6 months 6
6 months - 1 year 2
1 - 2 years 2
2 - 5 years 2
Adherence
Adherence Evaluations
Always 35
Usually 1
Sometimes 1
Never taken as prescribed 2
Burden
Burden Evaluations
Very hard to take 8
Somewhat hard to take 8
A little hard to take 13
Not at all hard to take 10
Cost per month
Cost per month Evaluations
$200+ 3
$100-199 0
$50-99 1
$25-49 3
< $25 19
Not specified 13

What people switch to and from

Patients started taking Benlysta after stopping:

Treatment Patients
Methotrexate (Apo-Methotrexate) 6
Mycophenolate mofetil (CellCept) 3
Prednisone (Deltasone) 3
Azathioprine (Imuran) 2
Leflunomide (Arava) 1

Show all 8 treatments patients report switching from

Patients stopped taking Benlysta and switched to:

Treatment Patients
Hydroxychloroquine (Plaquenil) 3
Methotrexate (Apo-Methotrexate) 1
Mycophenolate mofetil (CellCept) 1
Rituximab (Rituxan) 1
Sirolimus (Rapamune) 1
Last updated:

1 patient evaluation for Benlysta

Jul 24, 2013 (Started Aug 30, 2012)

  • Effectiveness
    Slight (for systemic lupus erythematosus)
  • Side effects
    Mild (headaches, nausea)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 580 mg Monthly

Oct 1, 2012 (Started Aug 30, 2012)

  • Effectiveness
    Can't tell (for systemic lupus erythematosus)
  • Side effects
    Moderate (headaches, nausea)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 580 mg Monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Benlysta